<?xml version="1.0" encoding="UTF-8"?>
<p>Administration of allogeneic MSC was also effective in critical limb ischaemia and no treatment-related adverse events were observed. Intramuscular injection of allogeneic umbilical cord blood-derived MSC in four patients with limb ischaemia related to Buerger's disease led to increased capillary formation and reduction in pain. There were no adverse events.
 <xref rid="R33" ref-type="bibr">33</xref> In a randomised placebo-controlled trial using allogeneic MSCs as treatment for critical limb ischaemia, an increase in ankle-brachial index and ankle pressure in the group treated with MSCs was seen. There were no treatment-related adverse events.
 <xref rid="R34" ref-type="bibr">34</xref>
</p>
